Trial
NCT05738161
Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
University of Bern; Swiss National Science Foundation
Condition
Advanced Urothelial Carcinoma
Intervention
Magrolimab
Why stopped
IMP security Issues reported by Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-05